J Appl Biomed 5:157-166, 2007 | DOI: 10.32725/jab.2007.021

Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ with acarbose in alloxan induced diabetic mice

Sachin L. Badole, Subhash L. Bodhankar*
Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, India

Mushrooms are a low calorie food with very little fat and are highly suitable for obese persons. The objective of the present investigation was to study the interaction of aqueous extract of P. pulmonarius (called PP-aqu) with acarbose on serum glucose levels, and on the oral glucose tolerance test (OGTT) in alloxan induced diabetic mice. PP-aqu (500 mg/kg), acarbose (50 mg/kg) and their combination were administered orally in alloxan (70 mg/kg i.v.) induced diabetic mice. In the acute study, the serum glucose level was estimated at 0, 2, 4, 6 and 24 h after drug administration. The subacute study involved repeated administration of the drugs for 28 days, a serum glucose level estimation at 7, 14, 21 and 28 days and recording of the body weights of the mice. In the OGTT, D-glucose (2.5 g/kg) was administered in diabetic mice half an hour after pre-treatment with PP-aqu (500 mg/kg), acarbose (50 mg/kg) and their combination. Serum glucose levels were estimated 30 min prior to glucose administration and at 0, 30, 60 and 120 min after glucose loading. The antihyperglycaemic effects of PP-aqu and acarbose alone were similar; i.e. the onset was 2 h, the peak effect was 6 h but the effect waned at 24 h. The effect of the combination of PP-aqu with acarbose was however different, as serum glucose was lower at 24 h. In the subacute study, repeated administration (once a day for 28 days) of the acarbose, PP-aqu and combination caused a significant (P

Keywords: P. pulmonarius; acarbose; alloxan diabetes; serum glucose; OGTT

Received: April 27, 2007; Published: July 31, 2007  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Badole SL, Bodhankar SL. Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ with acarbose in alloxan induced diabetic mice. J Appl Biomed. 2007;5(3):157-166. doi: 10.32725/jab.2007.021.
Download citation

References

  1. Abdel-Barry JA, Abdel-Hassan IA, Al-Hakiem MH: Hypoglycaemic and antihyperglycaemic effects of Trigonella foenum- graecum leaf in normal and alloxan induced diabetic rats. J. Ethnopharmacol. 58:149-155, 1997. Go to original source... Go to PubMed...
  2. Akhtar MS, Khan QM, Khaliq T: Effects of Portulaca oleracae (Kulfa) and Taraxacum officinale (Dhudhal) in normoglycaemic and alloxan-treated hyperglycaemic rabbits. J. Pak. Med. Assoc. 35:207-210, 1985. Go to PubMed...
  3. Awang DV, Fugh-Berman A: Herbal interactions with cardiovascular drugs. J. Cardiovasc. Nurs. 16:64-70, 2002. Go to original source... Go to PubMed...
  4. Badole SL, Shah SN, Patel NN, Thakurdesai PA, Bodhankar SL: Hypoglycemic activity of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ in alloxan induced diabetic mice. Pharm. Biol. 44:421-425, 2006a. Go to original source...
  5. Badole SL, Bodhankar SL, Thakurdesai PA: Study of interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ with rosiglitazone in alloxan induced diabetic mice. Pharmacologyonline 3:64-72, 2006b. Go to original source...
  6. Badole SL, Bodhankar SL, Thakurdesai PA: Study of interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ with glyburide in alloxan induced diabetic mice. Evid. Compl. Altern. Med. (e-CAM) 2007. (Article online). Go to original source...
  7. Bano Z: The Nutritive value of mushrooms. First Symposium on Survey and Cultivation of Edible Mushrooms of India, Regional Research Laboratory, Jammu 1976, pp. 148-169.
  8. Bressler R: Herb-drug interactions: interactions between kava and prescription medications. Geriatrics 60:24-25, 2005.
  9. Cheung PC, Lee MY: Fractionation and characterization of mushroom dietary fiber (nonstarch polysaccharides) as potential nutraceuticals from sclerotia of Pleurotus tuberregium (Fries) singer. J. Agric. Food. Chem. 48:3148-3151, 2000. Go to original source... Go to PubMed...
  10. Coxeter PD, McLachlan AJ, Duke CC, Roufogalis BD: Herb-drug interactions: an evidence based approach. Curr. Med. Chem. 11:1513-1525, 2004. Go to original source... Go to PubMed...
  11. Ewart RB, Kornfeld S, Kipnis DM: Effect of lectins on hormone release from isolated rat islets of langerhans. Diabetes 24:705-714, 1975. Go to original source... Go to PubMed...
  12. Flegg PB, Maw GA: Mushroom and their possible contribution to world protein needs. Mushroom J. 48:396-405, 1976.
  13. Food and Agriculture Organization of the United Nations. Food composition table for use in Africa. Vol ix. Bethesda, Md.: US Dept.of Health, Education, and Welfare, Nutrition Program, and Food Consumption and Planning Branch, Food and Agriculture Organization of the United Nations 1968.
  14. Fu H, Shieh DE: Antioxidant and free radical scavenging activities of edible mushrooms. J Food Lipids 9:35-46, 2002. Go to original source...
  15. Fugh-Berman A, Ernst E: Herb-drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol. 52:587-595, 2001. Go to original source... Go to PubMed...
  16. Gray AM, Flatt PR: Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J. Endocrinol. 157:259-266, 1998. Go to original source... Go to PubMed...
  17. Gumieniczek A, Hopkala H, Rolinski J, Bojarska-Junak A: Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals. Pharmacol. Res. 52:162-166, 2005. Go to original source... Go to PubMed...
  18. Hikino H, Takahashi M, Konno C, Ishimori A, Kawamura T, Namiki T: Effect of glycans of Saccharum officinarum on carbohydrate and lipid metabolism of rats. J. Ethnopharmacol. 14:261-268, 1985. Go to original source... Go to PubMed...
  19. Ishikawa Y, Morimoto K, Hamasaki T: Flavoglaucin, a metabolite of Eurotium Chevalieri, its antioxidation and synergism with tocopherol. J. Am. Oil Chem. Soc. 61:1864-1868, 1984. Go to original source...
  20. Izzo AA: Herb-drug interactions: an overview of the clinical evidence. Fundam. Clin. Pharmacol. 19:1-16, 2005. Go to original source... Go to PubMed...
  21. Kelly KM: Complementary and alternative medical therapies for children with cancer. Eur. J. Cancer 40:2041-2046, 2004. Go to original source... Go to PubMed...
  22. Khanna P, Garcha HS: Pleurotus mushroom - A source of food protein. Mushroom News Lett. Tropics 4:9-14, 1984.
  23. Konno S, Tortorelis DG, Fullerton SA, Samadi AA, Hettiarachchi J, Tazaki H: A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet. Med. 18: 1010, 2001. Go to original source... Go to PubMed...
  24. Kusano S, Abe H, Tamura H: Isolation of antidiabetic components from white-skinned sweet potato (Ipomoea batatas L.). Biosci. Biotechnol. Biochem. 65:109-114, 2001. Go to original source... Go to PubMed...
  25. Latha M and Pari L: Antihyperglycaemic effect of Cassia auriculata in experimental diabetes and its effects on key metabolic enzymes involved in carbohydrated metabolism. Clin. Exp. Pharmacol. Physiol. 30:38-43, 2003. Go to original source... Go to PubMed...
  26. Lebovitz HE: Alpha-glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Rev. 6:132-145, 1998.
  27. Lin YC, Bioteau AB, Ferrari LR, Berde CB: The use of herbs and complementary and alternative medicine in pediatric preoperative patients. J. Clin. Anesth. 16:4-6, 2004. Go to original source... Go to PubMed...
  28. Lindequist U, Niedermeyer TH, Julich WD: The pharmacological potential of mushrooms. Evid. Based Complement. Alternat. Med. 2: 285-299, 2005. Go to original source... Go to PubMed...
  29. Manohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG: Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes. Metab. 4:43-48, 2002. Go to original source... Go to PubMed...
  30. Mau JL, Lin HC, Song SF: Antioxidant properties of several specialty mushrooms. Food Res. Intern. 35:519-526, 2002. Go to original source...
  31. Miles PG, Chang ST: Mushroom Biology: Concise Basics and Current Development. World Scientific Publishing Company, New York 1997. Go to original source...
  32. Pan J, Chan EK, Cheta D, Schranz V, Charles MA: The effects of nicotinamide and glimepiride on diabetes prevention in BB rats. Life Sci. 57: 1525-1532, 1995. Go to original source... Go to PubMed...
  33. Poppenga RH: Herbal medicine: potential for intoxication and interactions with conventional drugs. Clin. Tech. Small Anim. Pract. 17:6-18, 2002. Go to original source... Go to PubMed...
  34. Ramkumar KM, Latha M, Venkateswaran S, Pari L, Ananthan R, Bai VN: Modulatory effect of Gymnema montanum leaf extract on brain antioxidant status and lipid peroxidation in diabetic rats. J. Med. Food. 7:366-371, 2004. Go to original source... Go to PubMed...
  35. Raptis SA, Dimitriadis GD: Oral hypoglycemic agents: insulin secretogogues, alpha-glucosidase inhibitors and insulin sensitizers. Exp. Clin. Endocrinol. Diabetes 109 (Suppl 2): 265-287, 2001. Go to original source... Go to PubMed...
  36. Reddy SV, Tiwari AK, Kumar US, Rao RJ, Rao JM: Free radical scavenging, enzyme inhibitory constituents from antidiabetic Ayurvedic medicinal plant Hydnocarpus wightiana Blume. Phytother. Res. 19:277-281, 2005. Go to original source... Go to PubMed...
  37. Sabu MC, Kuttan R: Antidiabetic activity of Aegle marmelos and its relationship with its antioxidant properties. Ind. J. Physiol. Pharmacol. 48:81-88, 2004.
  38. Samane S, Noel J, Charrouf Z, Amarouch H, Haddad PS: Insulin-sensitizing and antiproliferative effects of Argania spinosa seed extracts. Evid. Based Complement. Alternat. Med. 3:317-327, 2006. Go to original source... Go to PubMed...
  39. Siemianowicz K, Gminski J, Telega A, Wojcik A, Posielezna B, Grabowska-Bochenek R: Blood antioxidant parameters in patients with diabetic retinopathy. Int. J. Mol. Med. 14:433-437, 2004. Go to original source... Go to PubMed...
  40. Singh M, Varshneya C, Telang RS, Srivastava AK: Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens. J. Vet. Sci. 6:197-200, 2005. Go to original source... Go to PubMed...
  41. Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ: Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 10:69-73, 1989.
  42. Talpur N, Echard B, Dadgar A, Aggarwal S, Zhuang C, Bagchi D: Effects of Maitake mushroom fractions on blood pressure of Zucker fatty rats. Res. Commun. Mol. Pathol. Pharmacol. 112:68-82, 2002a. Go to PubMed...
  43. Talpur NA, Echard BW, Fan AY, Jaffari O, Bagchi D, Preuss HG: Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol. Cell. Biochem. 237:129-136, 2002b. Go to original source... Go to PubMed...
  44. Talpur N, Echard BW, Yasmin T, Bagchi D, Preuss HG: Effects of niacin-bound chromium, Maitake mushroom fraction SX and (-)-hydroxycitric acid on the metabolic syndrome in aged diabetic Zucker fatty rats. Mol. Cell. Biochem. 252:369-377, 2003. Go to original source... Go to PubMed...
  45. Takahasi M, Konno C, Hikino H: Isolation and hypoglycemic activity of Anemorans A, B, C and D, glycans of Anemarsrhema asphodelcides rhizomes. Planta Med. 51:100-102, 1985. Go to original source... Go to PubMed...
  46. Tribe I, Tosco U: The World of Mushrooms. Vol. viii. Orbis Publishing, London 1973.
  47. Windholz M: The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals. 10th ed. Merck & Co., New Jersey 1983.
  48. Woodward KN: The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Hum. Exp. Toxicol. 24:219-233, 2005. Go to original source... Go to PubMed...
  49. Wright T: Medicinal mushrooms. In Wright R (ed.): Nutraceutical World, Rodman publishing, Ramsay, New Jersey 2004, pp. 26-29.
  50. Yang JH, Lin H, C, Mau JL: Antioxidant properties of several commercial mushrooms. Food Chem. 77:229-235, 2002. Go to original source...
  51. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P: Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ. Res. 99: 494-500, 2006. Go to original source... Go to PubMed...